The choice between a ritonavir-boosted protease inhibitor- and a non-nucleoside reverse transcriptase inhibitor-based regimen for initiation of antiretroviral treatment – results from an observational study in Germany

BACKGROUND: This study aims at identifying predictors of the treatment decision of German physicians with regard to a non-nucleoside reverse transcriptase inhibitor (NNRTI) or a ritonavir-boosted protease inhibitor (PI/r) -based initial treatment regimen. METHODS: The study is based on a sub analysi...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Pharm Policy Pract
Auteurs principaux: Mahlich, Jörg, Groß, Mona, Kuhlmann, Alexander, Bogner, Johannes, Heiken, Hans, Stoll, Matthias
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2016
Sujets:
Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5203724/
https://ncbi.nlm.nih.gov/pubmed/28050254
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40545-016-0092-4
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires